[Experiences with cytostatic treatment of small cell bronchial cancer].
Reported are the results of cytostatic treatment in 32 patients with inoperable metastasized small cell bronchogenic carcinoma. With regard to the therapeutic effects 3 groups (A: limited disease, stage I-IIIa; B: extensive disease, stage IIIb; C: extensive disease II, stage IV) are compared. The application of a combined chemo-radiotherapy depends on the age, the general state and the stage of extension of the tumor. The polychemotherapy followed by the radiotherapy should be preferably applied to patients with tumors of the disease group A, because in this group the best results were obtained with an average survival time of 21.3 months, a remission length of 13.4 months, an improvement of life quality for 12.5 months and a high remission rate. The above mentioned therapy scheme is justifiable and practicable.
Wurbs
W
W
Medizinische Klinik des Bezirkskrankenhauses Halle, DDR.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011859:Radiography
Erfahrungen mit der zytostatischen Behandlung kleinzelliger Bronchialkarzinome.